{
  "pmcid": "11251114",
  "sha256": "82988f1b217c64cf977ae0bdc1d268f442db4c3d328bc6a17aaf53dda226fb5b",
  "timestamp_utc": "2025-11-09T23:13:53.543501+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.43593406593407,
    "reading_ease": 24.641923076923092,
    "word_count": 260
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Postoperative Immune Function in Minimal Access Breast Surgery and Conventional Open Breast Surgery"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included female patients aged 18-75 with cancer stages 0-III and no prior surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "829 breast cancer patients treated with MABS or conventional open breast surgery (COBS)"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was postoperative immune function, assessed by CD3+, CD4+, and CD8+ lymphocyte percentages and CD4+/CD8+ ratio, measured on preoperative day 1 (PreD1), postoperative day 1 (PostD1), and postoperative day 7 (PostD7) using flow cytometry."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Both MABS and COBS groups showed significant reductions in CD3+, CD4+, and CD8+ percentages and CD4+/CD8+ ratio from PreD1 to PostD1. By PostD7, the MABS group returned to preoperative levels, while the COBS group remained significantly lower."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "The study was not registered"
      },
      "Funding": {
        "score": 0,
        "evidence": "funding sources were not disclosed"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}